ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
41 hedge funds and large institutions have $18.6M invested in Elevation Oncology in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
61% less capital invested
Capital invested by funds: $47.9M → $18.6M (-$29.4M)
63.38% less ownership
Funds ownership: 129.57% → 66.18% (-63%)
Holders
41
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$474K | |
| 2 | +$102K | |
| 3 | +$71.9K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.3K |
| 5 |
Two Sigma Advisers
New York
|
+$50.9K |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$1.26M | |
| 3 | -$1.09M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$608K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$331K |